SEMA3B is downregulated in many epithelial tumors, such as glioma13 and esophageal squamous cell carcinoma,15 and could act as a prognostic index reflecting the immune infiltration of breast cancer patients.38 Here, SEMA3B is linked to breast carcinoma.